glucagon has been researched along with Shock in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 51 (92.73) | 18.7374 |
1990's | 3 (5.45) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (1.82) | 2.80 |
Authors | Studies |
---|---|
Daa, T; Gotoh, K; Kurosawa, K; Masaki, T; Mimata, H; Nakama, H; Okamoto, M; Shibata, H; Takekoshi, K | 1 |
Lefer, AM | 1 |
Herbert, P; Tinker, J | 1 |
Koop, H; Lankisch, PG | 1 |
Brambach, U; Eibs, HG; Oberdisse, U | 1 |
Assan, R; Bobbioni, E; Kronheim, S; Marre, M; Miller, J; Sheppard, M | 1 |
Adrian, TE; Bloom, SR; Clark, AJ; McMichael, HB | 1 |
Ettien, JT; Webster, PD | 1 |
Jones, RT; Linhardt, GE; Trump, BF | 1 |
Jaffe, BM; Modlin, IM | 1 |
Bond, JH; Levitt, MD | 1 |
Joye, F; Marion, F; Michoux, I; Orrillard, M; Parisot, R | 1 |
Faloona, GR; Lindsey, CA; Unger, RH | 1 |
Vaisrub, S | 1 |
Bank, S; Barbezat, GO; Marks, IN | 1 |
Brunner, H; Grabner, G; Wurm, E | 1 |
Daniel, AM; Liddell, MJ; MacLean, LD; Shizgal, HM | 1 |
Balibrea, JL; Garcia-Barreno, P | 1 |
Bartels, O; Junge, O; Topf, G | 1 |
Luyckx, A | 1 |
Olbermann, M; Pross, E; Schönborn, H | 1 |
Berk, JL | 1 |
Pinardi, G; Santiago, E; Vasquez, JV | 1 |
Barale, F; Clément, C | 1 |
Molloy, MG; O'Leary, P; O'Mahony, D | 1 |
Cernacek, P; Levy, M | 1 |
Chernow, B | 1 |
Chernow, B; Higgins, TL | 1 |
Bessey, PQ; Blazar, BA; Mannick, JA; O'Mahony, JB; Rodrick, ML; Wilmore, DW; Wood, JJ | 1 |
Filin, VI; Ianovskaia, SI; Krylov, AA | 1 |
van Zwieten, PA | 1 |
Goldberg, LI; Talley, RC | 1 |
Lvoff, R; Wilcken, DE | 1 |
Parmley, WW; Sonnenblick, EH | 1 |
Corbascio, AN; Smith, NT | 1 |
Evans, GT; Rapaport, E; Scheinman, M; Weiss, A | 1 |
Shimizu, R | 1 |
Späth, G | 1 |
Schröder, R | 2 |
Gagossi, M | 1 |
Bryan-Brown, CW; Shoemaker, WC | 1 |
Jacovella, G; Masini, V; Milazzotto, F | 1 |
Pippig, L | 1 |
Duff, JH; MacLean, LD; McLean, AP | 1 |
Grabensee, B; Mürtz, R; Veltmann, G | 1 |
Bing, RJ; Puri, PS | 1 |
Eddy, JD; O'Brien, ET; Singh, SP | 1 |
Beck, K; Kümmerle, F; Tenner, R | 1 |
Reynolds, EW; Vander Ark, CR | 1 |
Berkovits, B; Harken, DE; Manchester, JH; Matloff, JM; Parmley, WW; Sonnenblick, EH | 1 |
Bernard, S; Duchesne, G; Herman, B | 1 |
Lucchesi, BR; Stutz, DR; Winfield, RA | 1 |
Boszormenyi, E; Carvalho, M; Corday, E; Gold, H; Goldman, A; Lang, TW; Rosselot, E; Vyden, JK | 1 |
Steigerwaldt, F | 1 |
18 review(s) available for glucagon and Shock
Article | Year |
---|---|
Pharmacological modulation of myocardial depressant factor as a mediator of circulatory shock.
Topics: Blood Flow Velocity; Calcium; Cardiovascular Physiological Phenomena; Digitalis Glycosides; Dopamine; Glucagon; Humans; Isoproterenol; Myocardial Contraction; Myocardial Depressant Factor; Pancreas; Shock | 1989 |
Inotropic drugs in acute circulatory failure.
Topics: Adrenergic alpha-Agonists; Albuterol; Animals; Cardiotonic Agents; Catecholamines; Digitalis Glycosides; Dobutamine; Glucagon; Humans; Shock | 1980 |
[Current concept of diagnosis and therapy of acute pancreatitis (author's transl)].
Topics: Acute Disease; Acute Kidney Injury; Analgesics; Animals; Antacids; Anti-Bacterial Agents; Glucagon; Humans; Indomethacin; Intensive Care Units; Pancreatitis; Peritoneal Dialysis; Positive-Pressure Respiration; Rats; Respiratory Insufficiency; Shock; Somatostatin | 1980 |
The management of acute pancreatitis.
Topics: Acute Disease; Fluid Therapy; Glucagon; Humans; Infections; Pancreatitis; Parasympatholytics; Pulmonary Edema; Respiratory Insufficiency; Shock; Therapeutic Irrigation | 1980 |
[The treatment of acute pancreatitis in Austria: results of a questionnaire].
Topics: Acute Disease; Analgesics; Antacids; Anti-Bacterial Agents; Aprotinin; Austria; Calcitonin; Carbonic Anhydrase Inhibitors; Drinking; Fasting; Gastric Lavage; Germany, West; Glucagon; Humans; Infusions, Parenteral; Pancreas; Pancreatitis; Parasympatholytics; Shock; Somatostatin; Surveys and Questionnaires | 1979 |
[The role of glucagon in hyperglycemia. A review (author's transl)].
Topics: Acromegaly; Adult; Burns; Child; Cushing Syndrome; Diabetes Mellitus; Glucagon; Gluconeogenesis; Glucose; Humans; Hyperglycemia; Infections; Insulin; Islets of Langerhans; Liver; Liver Cirrhosis; Myocardial Infarction; Pancreatic Diseases; Pheochromocytoma; Prediabetic State; Shock; Somatostatin | 1975 |
[Acute necrotizing hemorrhagic pancreatitis].
Topics: Acute Disease; Atropine; Disseminated Intravascular Coagulation; Glucagon; Hemorrhage; Humans; Necrosis; Pain Management; Pancreatic Juice; Pancreatitis; Peritoneal Lavage; Prognosis; Shock; Tomography, X-Ray Computed; Ultrasonography | 1990 |
Glucagon: a potentially important hormone in circulatory shock.
Topics: Animals; Cardiovascular System; Glucagon; Humans; Shock | 1988 |
Pharmacotherapy of circulatory shock.
Topics: Cardiotonic Agents; Catecholamines; Glucagon; Hormones; Humans; Receptors, Adrenergic; Shock; Sympathomimetics; Water-Electrolyte Balance | 1987 |
[Changes in the cardiovascular system in acute pancreatitis].
Topics: Acute Disease; Adrenal Glands; Blood Volume; Cardiac Output; Cardiovascular System; Coronary Disease; Electrocardiography; Energy Metabolism; Glucagon; Hemodynamics; Humans; Liver Circulation; Microcirculation; Middle Aged; Myocardial Depressant Factor; Myocardium; Necrosis; Pancreatitis; Shock; Vascular Resistance | 1986 |
Drugs in cardiogenic shock.
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Arrhythmias, Cardiac; Blood Pressure; Cardiac Glycosides; Glucagon; Humans; Hypoxia; Plasma Substitutes; Shock; Shock, Cardiogenic; Sympathomimetics | 1973 |
Current therapy of shock.
Topics: Adrenergic alpha-Antagonists; Auscultation; Cardiac Glycosides; Dopamine; Epinephrine; Glucagon; Hemodynamics; Humans; Mephentermine; Methoxamine; Norepinephrine; Pulse; Shock; Shock, Hemorrhagic; Shock, Septic | 1971 |
The use and misuse of pressor agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Anesthesia, Spinal; Angiotensin II; Blood Vessels; Dopamine; Ephedrine; Epinephrine; Felypressin; Glucagon; Heart; Humans; Isoproterenol; Mephentermine; Metaraminol; Methamphetamine; Methoxamine; Norepinephrine; Phenylephrine; Shock; Vasoconstrictor Agents | 1970 |
[Shock and MDF].
Topics: Aged; Animals; Arrhythmias, Cardiac; Cats; Dogs; Electrocardiography; Female; Glucagon; Heart; Humans; Isoproterenol; Male; Middle Aged; Myocardial Infarction; Peptides; Shock; Shock, Cardiogenic | 1972 |
[Intensive medicine. Acute threatening metabolic disorders in diabetes mellitus].
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Coma; Diabetic Ketoacidosis; Diagnosis, Differential; Electrolytes; Emergencies; Glucagon; Glucose; Glycosuria; Humans; Hyperglycemia; Hypoglycemia; Infusions, Parenteral; Insulin; Insulin Resistance; Lactates; Mental Disorders; Neurologic Manifestations; Osmosis; Prognosis; Shock | 1972 |
[Modern trends in physiopathology and therapy of shock caused by myocardial infarct].
Topics: Adrenal Cortex Hormones; Digitalis Glycosides; Glucagon; Humans; Isoproterenol; Myocardial Infarction; Oxygen Inhalation Therapy; Plasma Substitutes; Shock; Sympathomimetics | 1969 |
[Treatment of acute myocardial infarct].
Topics: Acidosis; Analgesics; Arrhythmias, Cardiac; Cardiac Glycosides; Dextrans; Diuretics; Glucagon; Glucocorticoids; Heart Failure; Humans; Myocardial Infarction; Oxygen Inhalation Therapy; Potassium; Pulmonary Edema; Rest; Shock; Streptokinase; Time Factors; Tranquilizing Agents; Vasodilator Agents | 1970 |
The patient in shock. I.
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Arrhythmias, Cardiac; Arteries; Blood Pressure; Calcium Chloride; Cardiac Output; Cardiac Tamponade; Central Venous Pressure; Dopamine; Female; Glucagon; Hematocrit; Hemoglobins; Humans; Hydrogen-Ion Concentration; Isoproterenol; Lactates; Male; Myocardial Infarction; Oxygen; Pulse; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Surgical; Shock, Traumatic; Urination | 1971 |
37 other study(ies) available for glucagon and Shock
Article | Year |
---|---|
A case of adrenaline-predominant paraganglioma diagnosed with a state of shock after glucagon injection.
Topics: Aged; Female; Glucagon; Humans; Kidney Neoplasms; Paraganglioma; Shock; Tomography, X-Ray Computed | 2020 |
[Intoxication by beta-blockers in children and adolescents (author's transl)].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Child, Preschool; Female; Glucagon; Humans; Hypoglycemia; Propranolol; Shock; Sotalol; Suicide, Attempted | 1982 |
The nervous control of rat somatostatin, glucagon and insulin secretions.
Topics: Animals; Blood Pressure; Electric Stimulation; Glucagon; Insulin; Insulin Secretion; Liver Circulation; Male; Phentolamine; Portal System; Rats; Rats, Inbred Strains; Regional Blood Flow; Shock; Somatostatin; Splanchnic Nerves; Vagus Nerve | 1982 |
Vasoactive intestinal peptide in shock and heart failure.
Topics: Adult; Aged; Female; Gastrointestinal Hormones; Glucagon; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Pancreatic Polypeptide; Shock; Vasoactive Intestinal Peptide | 1983 |
Effects of pharmacological interventions on the rat liver following hypovolemic shock.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Dopamine; Glucagon; Liver; Male; Methylprednisolone; Rats; Rats, Inbred Strains; Shock | 1980 |
Clinical usefulness of glucagon.
Topics: Acute Disease; Animals; Endoscopy; Glucagon; Humans; Muscle, Smooth; Pancreatitis; Quinidine; Shock | 1980 |
Effect of glucagon on gastrointestinal blood flow of dogs in hypovolemic shock.
Topics: Animals; Cardiac Output; Colon; Dogs; Glucagon; Intestine, Small; Microspheres; Regional Blood Flow; Shock; Stomach; Strontium; Ytterbium | 1980 |
[Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon].
Topics: Adult; Alprazolam; Antipsychotic Agents; Benzodiazepines; Bradycardia; Carbamazepine; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Gastrointestinal Agents; Glucagon; Humans; Hypothermia; Infusions, Intravenous; Male; Methotrimeprazine; Olanzapine; Pirenzepine; Schizophrenia; Shock | 1999 |
PLasma glucagon levels during rapid exsanguination with and without adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Dogs; Glucagon; Hemorrhage; Hypotension; Insulin; Phentolamine; Propranolol; Receptors, Adrenergic; Shock; Time Factors | 1975 |
Editorial: Glucagon and shock.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Glucagon; Humans; Myocardial Infarction; Shock; Shock, Cardiogenic | 1975 |
Treatment of acute and chronic pancreatitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Alcohol Withdrawal Delirium; Anti-Bacterial Agents; Aprotinin; Brain Diseases; Celiac Disease; Chronic Disease; Diabetes Mellitus; Glucagon; Heart Diseases; Humans; Hypocalcemia; Infant, Newborn; Intestinal Obstruction; Jaundice; Kidney Diseases; Pain; Pancreatic Cyst; Pancreatitis; Parasympatholytics; Respiratory Distress Syndrome, Newborn; Serum Albumin; Shock; Water-Electrolyte Imbalance | 1977 |
The role of stress hormones in the catabolic metabolism of shock.
Topics: Animals; Blood Glucose; Carbon Dioxide; Dogs; Dose-Response Relationship, Drug; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Hormones; Hydrocortisone; Infusions, Parenteral; Lactates; Muscle Proteins; Oxidation-Reduction; Oxygen; Shock; Shock, Cardiogenic; Urea | 1979 |
Metabolic response in shock.
Topics: Acidosis; Animals; Blood Glucose; Blood Volume; Catecholamines; Dogs; Fatty Acids, Nonesterified; Glucagon; Glucose; Hyperglycemia; Hypoglycemia; Insulin; Lactates; Oxygen Consumption; Shock; Shock, Septic; Triglycerides | 1978 |
[Drug therapy of shock].
Topics: Bicarbonates; Dehydration; Dihydroergotoxine; Furosemide; Glucagon; Humans; Methylprednisolone; Peritoneal Dialysis; Plasma Substitutes; Shock; Shock, Cardiogenic; Shock, Septic; Spironolactone; Sympathomimetics; Theophylline | 1978 |
[Recent assumptions in conservative and surgical therapy of acute pancreatitis].
Topics: Abdomen, Acute; Acute Disease; Adult; Aprotinin; Brain Diseases; Edema; Female; Germany, West; Glucagon; Hemorrhage; Humans; Intensive Care Units; Male; Middle Aged; Necrosis; Oliguria; Pancreatitis; Patient Care Planning; Peritoneal Dialysis; Shock; Surgical Procedures, Operative | 1975 |
Use of vasoactive drugs in the treatment of shock.
Topics: Adrenal Cortex Hormones; Blood Pressure; Calcium; Cardiac Output; Catecholamines; Digitalis Glycosides; Dopamine; Drug Therapy, Combination; Epinephrine; Glucagon; Humans; Isoproterenol; Methoxamine; Norepinephrine; Phenoxybenzamine; Phentolamine; Propranolol; Shock; Vasoconstrictor Agents; Vasodilator Agents | 1975 |
Cardiovascular response to glucagon in hypovolemic dogs.
Topics: Animals; Aorta; Blood Pressure; Dogs; Female; Glucagon; Heart Rate; Hemodynamics; Male; Regional Blood Flow; Shock; Stimulation, Chemical; Time Factors; Vascular Resistance | 1975 |
Severe oxprenolol poisoning: the importance of glucagon infusion.
Topics: Adult; Blood Pressure; Dopamine; Female; Glucagon; Humans; Isoproterenol; Oxprenolol; Shock | 1990 |
Response to atrial natriuretic peptide in dogs with hypovolemic acute pancreatitis.
Topics: Acute Disease; Acute Kidney Injury; Animals; Atrial Natriuretic Factor; Dogs; Female; Glomerular Filtration Rate; Glucagon; Hemorrhage; Kidney; Male; Pancreatitis; Plasma Volume; Shock | 1989 |
Suppression of natural killer-cell function in humans following thermal and traumatic injury.
Topics: Adolescent; Adult; Aged; Burns; Cell Line; Cytotoxicity, Immunologic; Epinephrine; Glucagon; Humans; Hydrocortisone; Immunosuppression Therapy; Interleukin-2; Killer Cells, Natural; Leukemia, Myeloid, Acute; Male; Middle Aged; Monocytes; Neutrophils; Reference Values; Shock | 1986 |
Glucagon in resistant heart-failure and cardiogenic shock.
Topics: Adult; Bundle-Branch Block; Cardiac Glycosides; Cardiac Output; Cardiomegaly; Diuretics; Electrolytes; Glucagon; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Shock; Urea | 1970 |
A role for glucagon in cardiac therapy.
Topics: Animals; Blood Pressure; Cardiac Output; Cyclic AMP; Dogs; Glucagon; Heart; Heart Block; Heart Conduction System; Heart Diseases; Heart Rate; Heart-Lung Machine; Humans; Myocardial Infarction; Shock; Vascular Resistance | 1969 |
Relationship between pulmonary artery end-diastolic pressure and left ventricular filling pressure in patients in shock.
Topics: Blood Pressure; Carbon Dioxide; Cardiac Catheterization; Cardiac Volume; Diuretics; Electrocardiography; Glucagon; Heart Rate; Humans; Hydrogen-Ion Concentration; Isoproterenol; Norepinephrine; Oxygen; Oxygen Inhalation Therapy; Positive-Pressure Respiration; Pulmonary Artery; Shock | 1973 |
[Basic principles of the therapy of shock].
Topics: Blood Pressure; Blood Viscosity; Dopamine; Fibrinogen; Glucagon; Heart Rate; Humans; Hypotension; Injections, Intravenous; Isoproterenol; Metaproterenol; Norepinephrine; Oxygen Consumption; Plasma Substitutes; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Septic; Vasoconstrictor Agents; Vasodilator Agents | 1972 |
[Method for hemodynamic and metabolic evaluation of patients needing intensive therapy. In reference to the experiences of Dr. Siegel and coworkers].
Topics: Glucagon; Heart Failure; Hemodynamics; Humans; Intensive Care Units; Isoproterenol; Liver Cirrhosis; Metabolism; Myocardial Infarction; Shock | 1973 |
Resuscitation and immediate care of the critically ill and injured patient.
Topics: Accidents; Acid-Base Equilibrium; Airway Obstruction; Anti-Arrhythmia Agents; Blood Transfusion; Cardiac Output; Digitalis Glycosides; Emergencies; Glucagon; Glucose; Heart Arrest; Heart Massage; Hemodynamics; Hemorrhage; Humans; Hypotension; Hypoxia; Isoproterenol; Oxygen Consumption; Respiratory Tract Diseases; Resuscitation; Shock; Sympathomimetics; Tachycardia; Wounds and Injuries | 1973 |
[Internal shock control and therapy].
Topics: Glucagon; Glycosides; Humans; Intensive Care Units; Monitoring, Physiologic; Plasma Substitutes; Pulse; Shock | 1971 |
Effects of glucagon on myocardial contractility and hemodynamics in acute experimental myocardial infarction. Basis for its possible use in cardiogenic shock.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Glucagon; Heart; Heart Failure; Heart Rate; Hemodynamics; Myocardial Infarction; Shock; Vascular Resistance | 1969 |
Glucagon and haemodynamics of acute myocardial infarction.
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiac Volume; Glucagon; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Shock | 1969 |
[Life without a pancreas].
Topics: Aged; Calcium; Diabetes Mellitus; Female; Glucagon; Humans; Hypoglycemia; Male; Middle Aged; Pancreatectomy; Pancreatic Extracts; Pancreatic Neoplasms; Pancreatin; Postoperative Care; Postoperative Complications; Shock; Vitamin D; Zinc | 1970 |
Clinical evaluation of glucagon by continuous infusion in the treatment of low cardiac output states.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiac Output; Diuresis; Drug Stability; Female; Glucagon; Heart Failure; Heart Rate; Humans; Hypoglycemia; Injections, Intravenous; Male; Middle Aged; Shock; Time Factors; Water-Electrolyte Balance | 1970 |
Hemodynamic effects of glucagon and intraaortic balloon counterpulsation in canine myocardial infarction.
Topics: Animals; Assisted Circulation; Blood Pressure; Cardiac Output; Dogs; Glucagon; Heart-Lung Machine; Myocardial Infarction; Shock; Vascular Resistance; Ventricular Fibrillation | 1970 |
[Basic principles of shock therapy].
Topics: Blood Transfusion; Digitalis Glycosides; Dopamine; Glucagon; Humans; Isoproterenol; Metaproterenol; Norepinephrine; Phentolamine; Plasma Substitutes; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Septic | 1971 |
[Use of glucagon by continuous perfusion in the treatment of shock states].
Topics: Adult; Animals; Cats; Dogs; Drug Synergism; Female; Glucagon; Heart; Heart Conduction System; Heart Rate; Humans; Injections, Intravenous; Isoproterenol; Male; Middle Aged; Rabbits; Shock; Shock, Septic; Shock, Traumatic | 1971 |
Glucagon: its enhancement of atrioventricular nodal pacemaker activity and failure to increase ventricular automaticity in dogs.
Topics: Animals; Dogs; Glucagon; Heart Block; Heart Conduction System; Heart Ventricles; Hemostasis; Isoproterenol; Myocardial Infarction; Nerve Crush; Propranolol; Shock; Sinoatrial Node | 1969 |
Reevaluation of the treatment of shock secondary to cardiac infarction.
Topics: Adrenal Cortex Hormones; Animals; Blood Flow Velocity; Blood Pressure; Blood Volume; Cardiac Output; Coronary Vessels; Digitalis Glycosides; Dogs; Dopamine; Electrocardiography; Extracorporeal Circulation; Glucagon; Hemodynamics; Isoproterenol; Myocardial Infarction; Norepinephrine; Phenoxybenzamine; Propranolol; Shock; Vascular Resistance | 1969 |
[Glucagon in hypoglycemic conditions].
Topics: Blood Glucose; Diabetes Complications; Glucagon; Humans; Hyperinsulinism; Hypoglycemia; Insulin; Liver Function Tests; Shock | 1966 |